- Mike Ferrara | November 06, 2010 4:40 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
Drug giant GlaxoSmithKline is pleading guilty to criminal felony charges in an American investigation into its manufacturing practices at a Puerto Rico plant, and will pay $750 million in...
- Mike Ferrara | November 11, 2011 7:08 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
For the first time in history, more Americans are dying from drug-related causes than in auto accidents. According to a recent study by the CDC, in 2009, drugs killed more than 37,000 men, women and...
- Mike Ferrara | June 29, 2011 5:02 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
Last week, Justice Clarence Thomas authored an opinion for the Supreme Court finding that federal law preempts all state law cases against generic drug manufacturers who fail to sufficiently warn...
- Camryn Hansen | December 03, 2009 8:15 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
Following on the heels of the preemption victory in Wyeth v. Levine, in which the Supreme Court decided that consumers can sue a drug company for inadequate prescription drug labeling...
- Mike Ferrara | May 04, 2009 8:10 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
In the wake of a recent Massachusetts state ban on drug industry gifts to doctors and a Cleveland Clinic mandate requiring all its doctors to publicly report their financial ties to drug...
- Chrissie Cole | April 10, 2009 12:22 PM | Newark, NJ
Category:
FDA & Prescription Drugs
Genentech, Inc., the maker of the psoriasis drug Raptiva (generic name efalizumab) recently announced a phased voluntary withdrawal of the prescription only drug from the U.S. market.
The...
- Mike Ferrara | February 25, 2009 11:08 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
An Alabama jury ruled this week that drug giant Novartis will have to pay over $78 million in damages for overcharging the state’s Medicaid health program for generic drugs.
Finding that...
- Camryn Hansen | February 05, 2009 8:34 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
This week, open-access journal PLoS Medicine features a discussion on medical ghostwriting by leading scientists, denouncing ghostwriting as “scientific misconduct” which poses a...
- Camryn Hansen | January 10, 2009 11:16 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
Those who are frustrated by FDA leniency towards new, insufficiently tested and/or potentially dangerous drugs on the American market will be happy to know that the Caesar Millan of prescription...
- Mike Ferrara | October 09, 2008 8:11 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
New evidence emerging from the Merck lawsuits over the painkiller Vioxx shows that the company repeatedly lied to both the FDA and respected medical journals about who was conducting and writing...